Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...
The study presents data on the possible connection of respiratory pathologies like pneumonia in a cohort of dolphins with altered composition and concomitant perturbed biophysical properties of ...
The Long Lost Family presenter has opened up about how losing her sister Caroline to cancer in 2012 makes reuniting siblings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback